Status:
UNKNOWN
Comparative Study Between Two Adjuvant Drugs to Bupivacaine for Post-operative Epidural Analgesia in Abdominal Surgeries
Lead Sponsor:
Ain Shams University
Conditions:
Epidural Analgesia
Eligibility:
All Genders
21-70 years
Phase:
PHASE4
Brief Summary
Epidural analgesia is associated with early postoperative mobilization and rehabilitation with minimally associated pain and discomfort. Analgesic effect of local anesthetics is augmented by addition ...
Detailed Description
The aim of the study is to evaluate the effect of dexmedetomidin and fentanyl as adjuvants to bupivacaine for postoperative epidural analgesia in abdominal surgeries regarding block characteristics, p...
Eligibility Criteria
Inclusion
- ASA I or ASA II patients.
- Age group: 21-70 years old.
- BMI ≤40
- Duration of procedure ≤ 180 minutes.
Exclusion
- Patients with known neurologic and psychiatric illness will be excluded from the study.
- Contraindications for epidural anesthesia as patient refusal, bleeding or coagulation test abnormalities, local skin infection at spinal lumbar region, raised intracranial pressure and hypovolemia
- Spine abnormalities.
- Systemic disorders like hematological, respiratory, cardiac, renal or hepatic insufficiency.
- Allergy to any of the drugs used in the study.
Key Trial Info
Start Date :
August 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2022
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT05323214
Start Date
August 1 2021
End Date
September 30 2022
Last Update
July 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University Hospitals
Cairo, Egypt